Safety and efficacy of vorinostat, bortezomib, doxorubicin and dexamethasone in a phase I/II study for relapsed or refractory multiple myeloma (VERUMM study: vorinostat in elderly, relapsed and unfit multiple myeloma)

Guardat en:
Dades bibliogràfiques
Publicat a:Haematologica
Autors principals: Waldschmidt, Johannes M., Keller, Alexander, Ihorst, Gabriele, Grishina, Olga, Müller, Stefan, Wider, Dagmar, Frey, Anna V., King, Kristina, Simon, Roman, May, Annette, Tassone, Pierfrancesco, Duyster, Justus, Jung, Manfred, Raje, Noopur, Wäsch, Ralph, Engelhardt, Monika
Format: Artigo
Idioma:Inglês
Publicat: Ferrata Storti Foundation 2018
Matèries:
Online Only Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6165805/
https://ncbi.nlm.nih.gov/pubmed/29674494
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2018.189969
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars